Blackrock, INC Schedule 13G passive stakes

BlackRock, Inc. has increased its beneficial ownership in CH Robinson Worldwide Inc. to 7.8% of common stock, as disclosed in a recent Schedule 13G filing.

BlackRock, Inc. has reported an increased beneficial ownership in Cable One, Inc. common stock, now holding 12.7% of the class.

BlackRock, Inc. has reported an increased beneficial ownership of 6.1% in Colony Bankcorp Inc.'s common stock, holding 1,072,582 shares.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing an 8.2% beneficial ownership stake in Datadog, Inc.'s Class A Stock, totaling 26,588,343 shares.

BlackRock, Inc. has reported a 5.01% beneficial ownership stake in DELCATH SYS INC common stock as of September 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 4.96% in Digimarc Corporation's common stock.

BlackRock, Inc. has reported an increased beneficial ownership of 9.7% in DoubleVerify Holdings Inc., holding 15,910,993 shares of common stock.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 7.5% of Edwards Lifesciences Corp's common stock.

BlackRock, Inc. has reported an 8.9% beneficial ownership stake in Elanco Animal Health Inc., holding over 44 million shares of common stock.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.1% beneficial ownership stake in Equity Bancshares Inc.'s Class A Stock as of September 30, 2025.

BlackRock, Inc. has disclosed an aggregate beneficial ownership of 7.0% of Eventbrite, Inc.'s Class A Stock as of September 30, 2025, through its various business units.

BlackRock, Inc. has reported a 5.4% beneficial ownership stake in Alignment Healthcare, Inc., totaling 10,760,421 common shares.

BlackRock, Inc. has reported a 10.6% beneficial ownership stake in Allegiant Travel Company, holding 1,951,232 common shares as of September 30, 2025.

BlackRock, Inc. has reported an updated beneficial ownership of 5.1% in Anterix Inc., holding 950,842 shares of common stock as of September 30, 2025.

BlackRock, Inc. has reported a 5.4% beneficial ownership stake in Aura Biosciences Inc., holding 3,336,027 shares of common stock.

BlackRock, Inc. has filed an Amendment No. 5 to Schedule 13G, disclosing a continued beneficial ownership of 8.7% of Avantor, Inc.'s common stock as of September 30, 2025.

BlackRock, Inc. has reported a 5.3% beneficial ownership stake in BrightView Holdings Inc. common stock as of September 30, 2025.

BlackRock, Inc. has reported an increased beneficial ownership stake of 12.5% in Customers Bancorp Inc., holding 4,253,895 shares of common stock.

BlackRock, Inc. has reported a beneficial ownership of 8.0% of EMCOR Group Inc.'s common stock as of September 30, 2025.

BlackRock, Inc. has reported a 5.6% beneficial ownership stake in Advanced Flower Capital Inc., holding 1,269,688 common shares.

BlackRock, Inc. has reported a 5.8% beneficial ownership stake in Amprius Technologies Inc., holding over 7.2 million common shares.

BlackRock, Inc. has reported a 7.0% beneficial ownership stake in Archer Aviation Inc.'s Class A Stock, holding 45,379,325 shares as of September 30, 2025.

BlackRock, Inc. has reported a beneficial ownership of 4.3% in AVITA Medical, Inc. common stock, holding 1,138,436 shares.

BlackRock, Inc. has reported a 5.4% beneficial ownership stake in BV Financial Inc.'s common stock, holding 536,009 shares.

BlackRock, Inc. disclosed a 4.98% passive beneficial ownership in Bankwell Financial Group, Inc., holding 392,560 common shares.

BlackRock, Inc. has reported a significant 6.4% beneficial ownership stake in medical technology company BETA BIONICS INC, holding over 2.7 million shares.

BlackRock, Inc. has reported an increased beneficial ownership of 9.1% in Rapid7, Inc. common stock, holding 5,913,948 shares as of September 30, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a 12.0% beneficial ownership in RadNet, Inc. common stock as of September 30, 2025.

BlackRock, Inc. has reported an increased beneficial ownership of 14.4% in Penguin Solutions, Inc., holding 7,549,038 shares of common stock as of September 30, 2025.

BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, reporting a 14.6% beneficial ownership stake in NeoGenomics Inc. as of September 30, 2025.